MAP2K7 and non-small cell lung carcinoma: miR-21 promotes tumorigenesis through inhibition of negative regulators of the Ras/MEK/ERK signaling pathway (Hatley et al., 2010), suggesting that promising oncogenic functions of miR-21 in NSCLC.